Anakinra treatment efficacy in reduction of inflammatory biomarkers in COVID‐19 patients: A meta‐analysis-Reference-Cited by-同舟云学术

Anakinra treatment efficacy in reduction of inflammatory biomarkers in COVID‐19 patients: A meta‐analysis

Published:2022-04-18 Issue:6 Volume:36 Page:
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:Clinical Laboratory Analysis

Author:

Naveed Zunaira¹,Sarwar Musharraf²,Ali Zahid³,Saeed Danish⁴,Choudhry Khadija¹,Sarfraz Azza⁵^ORCID,Sarfraz Zouina¹^ORCID,Felix Miguel⁶⁷,Cherrez‐Ojeda Ivan⁶⁷

Affiliation:

1. Fatima Jinnah Medical University Lahore Pakistan

2. University College of Medicine and Dentistry Lahore Pakistan

3. Kyrgyz State Medical Academy Bishkek Kyrgyzstan

4. Shaikh Khalifa Bin Zayed Al‐Nahyan Medical and Dental College Lahore Pakistan

5. The Aga Khan University Karachi Pakistan

6. Universidad Espíritu Santo Samborondón Ecuador

7. Respiralab Research Group Guayaquil Ecuador

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcla.24434

Reference58 articles.

1. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages

2. Changes of hematological and immunological parameters in COVID-19 patients

3. High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients

4. Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine- Directed Therapies

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NFκB and NLRP3/NLRC4 inflammasomes regulate differentiation, activation and functional properties of monocytes in response to distinct SARS-CoV-2 proteins;Nature Communications;2024-03-07

2. Hyperferritinemic sepsis, macrophage activation syndrome, and mortality in a pediatric research network: a causal inference analysis;Critical Care;2023-09-06

3. A meta analysis on the utility of Anakinra in severe COVID-19 disease;Cytokine;2023-09

4. A Prospective Cohort Study of COVID-19: Evaluation of the Early Role of IL-1 and IL-6 Antagonists in Improving the Outcome of the Illness and Reduction in the Risk of Death;Healthcare;2023-04-03

5. Evaluation of anakinra in the management of patients with COVID-19 infection: A randomized clinical trial;Frontiers in Microbiology;2023-01-26